Doctor Anna Gvozdeva
National Medical Research Center for Cardiology, Moscow (Russian Federation)
Angiotensin neprilysin inhibition in HFpEF and advanced left ventricular hypertrophy: the rationale, design, and preliminary results of a randomized open-label pilot study
Event: Heart Failure 2021
Topic: Pharmacotherapy
Session: ePoster session
ESC 365 is supported by
